Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BRL 101

Next Previous
Drug Profile

BRL 101

Alternative Names: BRL-101

Latest Information Update: 25 Sep 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BRL Medicine
  • Class Gene therapies; Haematopoietic stem cells therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Beta-thalassaemia
  • Preclinical Sickle cell anaemia

Most Recent Events

  • 13 Jun 2024 Pooled efficacy and safety data from phase I/II trials in Beta-thalassaemia presented at the 29th Congress of the European Haematology Association (EHA-2024)
  • 12 Mar 2024 BRL Medicine plans a clinical trial for Beta-thalassaemia (In adults, In adolescents, In children) in China (IV, Infusion) in December 2024 (NCT06298630)
  • 08 Mar 2024 BRL Medicine plans a clinical trial for Sickle cell anaemia (In children, In adolescents, In adults) in China (IV, Infusion) (NCT06300723)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top